Xilio Therapeutics, Inc. (XLO) Insider Trading

Name: Xilio Therapeutics, Inc. (XLO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Houvras Yariv (CHIEF MEDICAL OFFICER): Grant/Award of 105,000 shares.

Get alerted when insiders trade XLO

Email address

Loading company data...

Beta

Loading company details...

Beta